Health Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors July 6, 2022
Health Outlook Therapeutics Announces Full Cash Pre-Payment of Convertible Promissory Note July 5, 2022
Health Fulcrum Therapeutics Enrolls First Patient in Pivotal Global Phase 3 Clinical Trial of Losmapimod for Facioscapulohumeral Muscular Dystrophy (FSHD) July 5, 2022
Health Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent From USPTO June 30, 2022
Health Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders June 30, 2022
Health Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders June 30, 2022
Health Publication Highlights Potential Clinical Applications of the HTG Transcriptome Panel in Bladder Cancer June 29, 2022
Health Evofem Reaches Agreement with One of the Largest Pharmacy Benefit Managers in the U.S. for Access to Phexxi® June 28, 2022
Health Hillstream BioPharma Announces Collaboration with Sapien Biosciences in Cancer Treatments June 27, 2022